![Daniella Beckman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniella Beckman
Directeur/Bestuurslid bij
VOR BIOPHARMA INC.
Vermogen: 4 M $ op 31-07-2026
Profiel
Daniella Beckman is Lead Independent Director at Vor Biopharma, Inc. since 2026 and Independent Director at Upstream Bio, Inc. since 2024.
Former roles include Independent Director at Blueprint Medicines Corp.
from 2021 to 2025, Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022, Independent Director at Translate Bio, Inc. from 2017 to 2021, Chief Financial Officer & PAO at Tango Therapeutics, Inc. from 2016 to 2026, Chief Financial Officer at BioNTech US, Inc. from 2015 to 2019, Chief Financial Officer at Beckman Consulting LLC from 2015 to 2019, CFO, Treasurer, Director & Vice President at Idenix Pharmaceuticals LLC from 2011 to 2014.
Education includes undergraduate studies at Boston University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2026 | 131.689 ( 0,12% ) | 4 M $ | 31-07-2026 | |
UPSTREAM BIO, INC. -.--% | 09-06-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
VOR BIOPHARMA, INC. -.--% | 11-06-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van Daniella Beckman
| Bedrijven | Functie | Begin |
|---|---|---|
| VOR BIOPHARMA INC. | Directeur/Bestuurslid | 16-07-2020 |
| UPSTREAM BIO, INC. | Directeur/Bestuurslid | 11-10-2024 |
Eerdere bekende functies van Daniella Beckman
| Bedrijven | Functie | Einde |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Financieel Directeur/CFO | 15-04-2026 |
| BLUEPRINT MEDICINES CORPORATION | Directeur/Bestuurslid | 17-07-2025 |
| 501 ACQU | Directeur/Bestuurslid | 01-01-2022 |
| TRANSLATE BIO, INC. | Directeur/Bestuurslid | 14-09-2021 |
| NEON THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-09-2019 |
Opleiding van Daniella Beckman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Beckman Consulting LLC
 Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Engages in the provision of consulting services | Commercial Services |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
